Shanghai No.1 Pharmacy Co.,Ltd. (SHA:600833)
China flag China · Delayed Price · Currency is CNY
8.98
-0.15 (-1.64%)
Nov 18, 2026, 3:00 PM CST

Shanghai No.1 Pharmacy Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
2,0532,0701,8641,7672,6171,342
Other Revenue
59.7459.7451.3552.2338.556.25
2,1132,1301,9151,8202,6561,398
Revenue Growth
1.32%11.23%5.26%-31.49%89.94%-11.89%
Cost of Revenue
1,7891,7901,5981,4742,1161,153
Gross Profit
323.73340.08317.2345.21540.36244.86
Selling, General & Admin
328.72339.61318.56315.85307.58230.69
Other Operating Expenses
6.055.965.888.369.534.71
Operating Expenses
337.3346.04305.27333.8333.73235.93
Operating Income
-13.57-5.9711.9311.41206.638.94
Interest Expense
-3.22-4.51-6.05-7.59-14.12-3.15
Interest & Investment Income
20.1125.0933.8625.3117.8924.23
Currency Exchange Gain (Loss)
-1.59-1.59-0.180.190.05-
Other Non Operating Income (Expenses)
-7.66-0.83.42-3.4-3.940.26
EBT Excluding Unusual Items
-5.9312.2242.9825.92206.5130.27
Gain (Loss) on Sale of Investments
0.24-0.010.3812.140.29-
Gain (Loss) on Sale of Assets
31.6949.84168.8964.73-0.071.23
Asset Writedown
-1.3-1.3-4.99-4.69-19.99-
Other Unusual Items
15.315.39.0219.413.7933.75
Pretax Income
39.9976.05216.27117.51190.5265.24
Income Tax Expense
8.0517.5152.6628.2446.9615.82
Earnings From Continuing Operations
31.9458.54163.6289.28143.5649.42
Minority Interest in Earnings
-0.56-0.79-0.55---
Net Income
31.3857.75163.0689.28143.5649.42
Net Income to Common
31.3857.75163.0689.28143.5649.42
Net Income Growth
-54.52%-64.59%82.65%-37.81%190.49%-27.90%
Shares Outstanding (Basic)
222222223223224225
Shares Outstanding (Diluted)
222222223223224225
Shares Change
-0.56%-0.57%0.08%-0.50%-0.14%1.60%
EPS (Basic)
0.140.260.730.400.640.22
EPS (Diluted)
0.140.260.730.400.640.22
EPS Growth
-54.27%-64.38%82.50%-37.50%190.91%-29.03%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
58.272.95-2.9144.61120.9423.92
Free Cash Flow Per Share
0.260.33-0.010.200.540.11
Dividend Per Share
0.0780.0780.2200.1250.1950.070
Dividend Growth
-64.55%-64.55%76.00%-35.90%178.57%-26.32%
Gross Margin
15.32%15.96%16.56%18.97%20.34%17.51%
Operating Margin
-0.64%-0.28%0.62%0.63%7.78%0.64%
Profit Margin
1.49%2.71%8.51%4.91%5.41%3.53%
Free Cash Flow Margin
2.75%3.43%-0.15%2.45%4.55%1.71%
EBITDA
-6.491.319.4318.79214.2516.71
EBITDA Margin
-0.31%0.06%1.01%1.03%8.07%1.20%
D&A For EBITDA
7.087.267.517.387.627.77
EBIT
-13.57-5.9711.9311.41206.638.94
EBIT Margin
-0.64%-0.28%0.62%0.63%7.78%0.64%
Effective Tax Rate
20.14%23.03%24.35%24.03%24.65%24.25%
Revenue as Reported
2,1132,1301,9151,8202,6561,398
Advertising Expenses
-5.086.116.64.752.99